Evidence map›Paper›PMID 34462959›Full record

ArticleThe International journal of health planning and management2022

Impact of COVID-19 pandemic on viral hepatitis in Africa: Challenges and way forward.

Zainab Ismail, Abdullahi Tunde Aborode, Ajagbe Abayomi Oyeyemi, Hiba Khan, Mohammad Mehedi Hasan, Anwesha Saha, Blessing Akah

Open access · greenAbstract readLetter
In one paragraph

Article in The International journal of health planning and management, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Malaria vaccine: The lasting solution to malaria burden in Africa.Annals of medicine and surgery (2012) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 6 countries.

Zainab IsmailFaculty of Medicine, Menoufia University, Menoufia, Egypt.
Abdullahi Tunde AborodeHealthy Africans Platform, Research and Development, Ibadan, Nigeria.ORCID https://orcid.org/0000-0003-2516-5920
Ajagbe Abayomi OyeyemiDepartment of Anatomy, Nile University of Nigeria, Abuja, Nigeria.
Hiba KhanDubai Medical College, Dubai, UAE.
Mohammad Mehedi HasanDepartment of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.ORCID https://orcid.org/0000-0002-3871-889X
Anwesha SahaDepartment of Biotechnology, Heritage Institute of Technology, Kolkata, West Bengal, India.
Blessing AkahTexas Tech University, Lubbock, Texas, USA.
Texas Tech University · USDubai Medical College · AEMaulana Abul Kalam Azad University of Technology, West Bengal · INMenoufia University · EGNile University of Nigeria · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the overwhelming COVID-19 pandemic in Africa, many other severe epidemics have been given low priority, such as viral hepatitis. Patient mortality due to viral hepatitis has raised concern to COVID-19 patients due to compromise with undiagnosed hepatitis in Africa. The pandemic has worsened the control of the viral hepatitis epidemic as healthcare control facilities have moved their focus towards curbing COVID-19 infections. However, different challenges have arisen to viral hepatitis patients because of low health attention that declines the progress of already diagnosed hepatitis patients. Follow-up plans, routine testing and treatment plans for viral hepatitis are no longer as strict with the human resources transferred towards combating the pandemic. Thus, a global effort is required to abide by renewed recommendations to eradicate viral hepatitis in Africa that also fit the current picture of the COVID-19 pandemic. The article discusses the current challenges viral hepatitis patients faced during the COVID-19 pandemic and important recommendations that can see through these challenges in Africa.

Indexed as

COVID-19Hepatitis, Viral, HumanAfricaHumansPandemicsSARS-CoV-2AfricaCOVID-19pandemicpublic healthviral hepatitis

Identifiers

PMID34462959
PMCPMC8653283
OpenAlexW3196539230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.